Secondary myelodysplastic syndrome after treatment of prostate cancer with oral estramustine
- 2 July 2001
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 67 (4) , 274-275
- https://doi.org/10.1002/ajh.1133
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Secondary acute myelogenous leukemia following treatment with oral etoposideAmerican Journal of Hematology, 1996
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145)Journal of Urology, 1982